Sterile Processing Professionals Provide Insights to Help Guide the
Future of Infection Control and Patient Safety
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Verrix,
a developer of solutions for rapid and accurate sterilization
confirmation, engaged with sterile processing professionals while
exhibiting at the recent International Association of Healthcare Central
Service Materiel Management 2019 Annual Conference & Expo.
Verrix founder and NASA Jet Propulsion Laboratory scientist Adrian
Ponce, Ph.D., met with conference attendees to share how the company is
developing new solutions for healthcare that leverage “rocket science”
technology originally invented at NASA’s Jet Propulsion Laboratory. The
Verrix technology is designed to provide sterilization confirmation
results with unparalleled speed and accuracy.
During the conference, the company asked attendees to share their vision
for the future of infection control and patient safety. “Sterile
processing professionals are looking for more advanced technology
solutions that will simplify and improve workflows for their
increasingly complex jobs,” said Cameron Rouns, Verrix CEO. “Their
thoughtful comments highlighted our shared vision for a future with zero
healthcare-associated infections from preventable causes.”
Rouns also noted that a critical component of the IAHCSMM annual
conference is the opportunity for central service and sterile processing
professionals to attain continuing education credits needed for
certification. “Verrix strongly supports continuing education and the
advancement of the sterile processing profession, and provided several
$500 vouchers during the conference to further the educational needs of
members,” he said. “As we look toward the future, we will continue
listening to sterile processing professionals, supporting their
advancement, and innovating based on their needs.”
About Verrix
Verrix is a San Clemente, Calif.-based medical device company that is
using the most advanced technologies to help protect patients from
healthcare-associated infections. The foundational sterility assurance
technology, originally discovered at NASA’s Jet Propulsion Laboratory,
integrates cutting-edge optical physics, chemistry spectroscopy, and
molecular biology. Based on scientific expertise and close partnerships
with healthcare professionals, Verrix is developing market-changing
solutions for sterility assurance, environmental monitoring, and
infection control. Visit www.verrix.com
for more information.
Contacts
Media Contact
Andrea Sampson, Sullivan & Sampson PR, [email protected],
714/374-6174
Erin Manning, Vice President, Marketing, Verrix, [email protected],
949/668-1229
